Brian Johnston

TransMedics Group, Inc. (TMDX)

Analyst

Introductory Commentator

Analyst

Gilmartin Group

Artivion, Inc. (AORT)

Outset Medical, Inc. (OM)

Head of Investor Relations

Ceribell, Inc. (CBLL)

Equibles does not estimate personal net worth.

Get an email with a short summary when TransMedics Group, Inc. publishes a filing, an earnings call transcript or a press release.

Get TMDX alerts

About Brian Johnston

Brian Johnston is recorded as Analyst at Introductory Commentator, Analyst at Gilmartin Group and Head of Investor Relations at Ceribell, Inc. (CBLL). Brian Johnston has spoken on 21 earnings calls across 4 companies, most recently for Artivion, Inc. on November 5, 2026. Those appearances were for TransMedics Group, Inc. (TMDX), Ceribell, Inc. (CBLL), Artivion, Inc. (AORT) and Pulmonx Corp (LUNG). TransMedics Group, Inc. is classified in the Medical Devices industry within the Healthcare sector. Ceribell, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other companies whose calls Brian Johnston spoke on are classified in the Healthcare sector. Other leadership on record at TransMedics Group, Inc. includes Waleed Hassanein (CEO and Board Member), Fernando Araujo (CFO), Gerardo Hernandez (CFO) and 7 others.

Brian Johnston on recent calls

“Joining me from our Tivian's management team are Pat Mackin, CEO, and Lance Ferry, COO and CFO. Before we begin, I would like to make the following statements to comply with the safe harbor requirements of the Private Securities Litigation Reform Act of 1995.”

Host, Q3 2026 Artivion, Inc. Earnings Conference Call · November 5, 2026

“You may begin. good afternoon and thank you for joining the call today joining me from our tivian's management team are pat macken ceo and lance berry ceo and cfo before we begin i'd like to make the following statements to comply with the safe harbor requirements of the private securities litigation reform act of…”

Artivion, Inc. Q2 FY2026 Earnings Call · August 6, 2026

“Joining me from Sarabelle are Jane Chow, co-founder and chief executive officer, and Scott Blumberg, chief financial officer. Earlier today, Sarabelle issued a press release announcing financial results for the quarter ended March 31, 2026.”

Head of Investor Relations, Ceribell, Inc. Q1 FY2026 Earnings Call · May 11, 2026

“Joining me from Sarabelle are Jane Chow, co-founder and chief executive officer, and Scott Blumberg, chief financial officer. Earlier today, Sarabelle issued a press release announcing financial results for the quarter and year-ended December 31, 2025.”

Head of Investor Relations, Ceribell, Inc. Q4 FY2025 Earnings Call · February 24, 2026

“Joining me from Sarabelle are Jane Chow, co-founder and chief executive officer, and Scott Blumberg, chief financial officer. Earlier today, Sarabelle issued a press release announcing financial results for the quarter ended September 30th, 2025.”

Head of Investor Relations, Ceribell, Inc. Q3 FY2025 Earnings Call · November 4, 2025